Patients with asthma who do not fill their inhaled corticosteroids: A study of primary nonadherence

被引:128
|
作者
Williams, L. Keoki
Joseph, Christine L.
Peterson, Edward L.
Wells, Karen
Wang, Mingqun
Chowdhry, Vimal K.
Walsh, Matthew
Campbell, Janis
Rand, Cynthia S.
Apter, Andrea J.
Lanfear, David E.
Tunceli, Kaan
Pladevall, Manel
机构
[1] Henry Ford Hosp, Dept Internal Med, Detroit, MI 48202 USA
[2] Henry Ford Hosp, Ctr Hlth Serv Res, Detroit, MI 48202 USA
[3] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA
[4] Hlth Alliance Plan, Detroit, MI USA
[5] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
[6] Univ Penn, Med Ctr, Dept Med, Philadelphia, PA 19104 USA
关键词
primary nonadherence; inhaled corticosteroids; asthma race-ethnicity; controller medication;
D O I
10.1016/j.jaci.2007.08.020
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Adherence to inhaled corticosteroids (ICSs) is known to be poor among patients with asthma; however, little is known about patients who do not fill their ICS prescriptions (ie, primary nonadherence). Objective: To estimate rates of primary nonadherence and to explore associated factors. Methods: The study population was members of a large health maintenance organization in southeast Michigan who met the following criteria: age 5 to 56 years; previous diagnosis of asthma; at least I electronic prescription for an ICS between February 17, 2005, and June 1, 2006; and at least 3 months follow-tip after the ICS prescription. Adherence was estimated by using electronic prescription information and pharmacy claims data. Multivariable stepwise analysis was used to identify factors associated with primary nonadherence compared with adherent patients. Results: One thousand sixty-four patients met the study criteria and bad calculable adherence. Of these patients, 82 (8%) never filled their ICS prescription. Stepwise regression identified the following factors to be associated with an increased likelihood of primary nonadherence: younger age, female sex, African American race-ethnicity, and lower rescue medication use. Factors associated with primary nonadherence differed between race-ethnic groups. Conclusion: Primary nonadherence was associated with lower baseline rescue medication use, which may reflect lower perceived need for ICS therapy in patients with milder asthma. Rates of primary nonadherence and the factors which influenced this outcome differed by race-ethnicity. Clinical implications: Understanding patient characteristics associated with primary nonadherence may be important for disease management, because many patients with asthma do not fill their ICS prescriptions.
引用
收藏
页码:1153 / 1159
页数:7
相关论文
共 50 条
  • [31] Do inhaled corticosteroids protect against lung cancer in patients with COPD? A systematic review
    Raymakers, Adam J. N.
    McCormick, Natalie
    Marra, Carlo A.
    Fitzgerald, J. Mark
    Sin, Don
    Lynd, Larry D.
    RESPIROLOGY, 2017, 22 (01) : 61 - 70
  • [32] Demographic disparities in patient-reported use of inhaled corticosteroids among patients with persistent asthma
    Vaidya, Varun
    Holiday-Goodman, Monica
    Pinto, Sharrel
    JOURNAL OF ASTHMA AND ALLERGY, 2010, 3 : 101 - 106
  • [33] Effect of Inhaled Corticosteroids on Long-Term Growth in Pediatric Patients with Asthma and Allergic Rhinitis
    Hoover, Rebecca M.
    Erramouspe, John
    Bell, Edward A.
    Cleveland, Kevin W.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (09) : 1175 - 1181
  • [34] Inhaled Corticosteroids Should Be Initiated Before Discharge from the Emergency Department in Patients with Persistent Asthma
    Self, Timothy H.
    Twilla, Jennifer D.
    Rogers, Maegan L.
    Rumbak, Mark J.
    JOURNAL OF ASTHMA, 2009, 46 (10) : 974 - 979
  • [35] Changes in indices of airway hyperresponsiveness during one year of treatment with inhaled corticosteroids in patients with asthma
    Oga, T
    Nishimura, K
    Tsukino, M
    Hajiro, T
    Ikeda, A
    JOURNAL OF ASTHMA, 2001, 38 (02) : 133 - 139
  • [36] Use of salmeterol with and without concurrent use of inhaled corticosteroids and the risk of asthma-related hospitalization among patients with asthma
    Wang, Meng-Ting
    Skrepnek, Grant H.
    Armstrong, Edward
    Sherrill, Duane L.
    Harris, Robin B.
    Tsai, Cheng-Liang
    Malone, Daniel C.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (03) : 859 - 867
  • [37] Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study
    Pierre Ernst
    Sophie Dell'Aniello
    Yann Mikaeloff
    Samy Suissa
    BMC Pulmonary Medicine, 11
  • [38] Factors associated with adherence to asthma treatment with inhaled corticosteroids: A cross-sectional exploratory study
    Lawani, Moulikatou Adouni
    Zongo, Frank
    Breton, Marie-Claude
    Moisan, Jocelyne
    Gregoire, Jean-Pierre
    Dorval, Eileen
    Boulet, Louis-Philippe
    Jobin, Marie-Sophie
    Guenette, Line
    JOURNAL OF ASTHMA, 2018, 55 (03) : 318 - 329
  • [39] Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy
    Allen-Ramey, Felicia C.
    Bukstein, Don
    Luskin, Allan
    Sajjan, Shiva G.
    Markson, Leona E.
    JOURNAL OF MANAGED CARE PHARMACY, 2006, 12 (04): : 310 - 321
  • [40] Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study
    Vahatalo, Iida
    Ilmarinen, Pinja
    Tuomisto, Leena E.
    Niemela, Onni
    Kankaanranta, Hannu
    RESPIRATORY MEDICINE, 2018, 137 : 70 - 76